about
Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosusPerspectives and limitations of gene expression profiling in rheumatology: new molecular strategiesIdentification of Candidate Predictors of Lupus FlareDistinct regulation of murine lupus susceptibility genes by the IRF5/Blimp-1 axisAim2 deficiency stimulates the expression of IFN-inducible Ifi202, a lupus susceptibility murine gene within the Nba2 autoimmune susceptibility locus.The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients.Protein arrays for studying blood cells and their secreted products.The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus.Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic DiseasesAssessing the human immune system through blood transcriptomics.Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.Systemic lupus erythematosus diagnostics in the 'omics' eraA genomic approach to human autoimmune diseases.Type I interferon in the pathogenesis of lupus.Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis.Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNsNovel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis.Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunityAccelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.Targeting of type I interferon in systemic autoimmune diseasesInduction of 150-kDa adenosine deaminase that acts on RNA (ADAR)-1 gene expression in normal T lymphocytes by anti-CD3-epsilon and anti-CD28.Novel therapeutic agents in clinical development for systemic lupus erythematosus.Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosusGene expression profiling in monocytes and SNP association suggest the importance of the STAT1 gene for osteoporosis in both Chinese and Caucasians.The dysregulation of cytokine networks in systemic lupus erythematosus.Antigen is required for maturation and activation of pathogenic anti-DNA antibodies and systemic inflammation.Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosusThe type I interferon system in the etiopathogenesis of autoimmune diseases.Emerging roles for the interferon-inducible p200-family proteins in sex bias in systemic lupus erythematosus.Interferons in autoimmune and inflammatory diseases: regulation and roles.Targeting interferon regulatory factors to inhibit activation of the type I IFN response: implications for treatment of autoimmune disorders.Microarray analysis of interferon-regulated genes in SLE.Identification of molecular biomarkers for multiple sclerosis.Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus.Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.An array of possibilities for the study of autoimmunity.Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies.
P2860
Q24530690-D31EB50A-04AC-484D-926A-ED7AB2E81AD0Q24805489-0D6DFB85-D01E-4313-98CE-CFE8C21153E6Q26795372-FB9A6667-E75C-4182-80E0-4CE9A3C1A0FFQ30423162-4AE368EF-2C6F-4AA3-B4A0-A5FA190131FCQ30429300-452F63C8-9DB6-4FFF-AFC4-67016E832981Q30497355-8EDE680C-2C61-4EE8-A053-14D402941C86Q30817633-EC006BDB-565E-4E3F-922B-5F66175E0E21Q33213208-4A8F2A33-AE2A-4DC7-A1DC-16A9FD53CD91Q33532591-6C47BCB3-F0BD-4DAC-A445-954744FCC4E1Q33563703-25DBD823-2C61-4140-9AC8-9103EDD325B1Q33629522-800F1E0C-CBE1-46A5-9C5B-A1B2C91265F8Q33636927-0FF49B3B-125D-416D-B8AC-8EFE4E103458Q33644106-0F6C27C0-3413-4448-8FD1-99D894C8FDDFQ33762839-7DB52815-9E38-4919-9573-9CA830028DAEQ33852174-EEBD63BB-3A4E-4B20-A9AB-A047715F8D89Q33877996-F341F046-52A3-4871-85DA-0E4979B63294Q34017633-DE983F2B-AA70-4166-BD86-C1FB0937E3F4Q34089816-C496F82C-F5C6-43B6-9C02-5D5E0F27C9F3Q34110028-9AD9CC93-1A48-4A3F-9F62-85587F9B8E6BQ34163340-EFABB511-2237-424C-BDC2-23EB761253BCQ34170097-E11DDCC8-AA6A-45F7-8A6B-1101B9BCD0C2Q34273836-498E15AF-C2AD-42B2-8365-9BAAA22224A8Q34451758-31684142-8C02-40F7-A746-AA8F25AD8FB5Q34655091-18F0B946-6B62-4C74-824C-0F37A087616DQ34704902-287C1F69-B214-4791-A8FA-E5349085EE61Q35093004-3AD50E42-3408-4678-902D-38A52EC60EF1Q35156259-9360ADE1-354A-42DC-B3FB-165543FD83F3Q35294513-0ACC9B3C-8E27-4AC8-AF4A-EC4997368DECQ35334977-7CCC75A3-127D-4FF4-85E4-658574B97D4AQ35512674-6F5E46BC-8AB5-4C28-891F-63BC7FE11F30Q35514368-EDB63B2A-1A0E-401F-8BF2-F158981DCB1CQ35603591-E5E598E3-9B44-439C-A4F1-F17BEF5B3C64Q35603598-5375E4FD-0655-415F-9B92-8DDD9364C399Q35640356-28BF2CFB-A9A6-4B78-82F6-38D7ECCA5C15Q35675519-00F04EA1-2634-4A8A-8A3B-01DF8D934AF8Q35789583-1BAD721F-82AE-44AC-8256-13ECF0E5387DQ35824472-8B2B7574-0507-43C1-BC1B-EE338149B7EDQ35911103-C1D0C330-39C1-45AB-855E-8E5CD0FE623BQ36148412-C0FBAEB2-B46A-44B5-B165-F670A582EEC0Q36412663-3A0611AD-8351-44D7-BE01-6996F52B4854
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Microarray analysis of gene expression in lupus
@ast
Microarray analysis of gene expression in lupus
@en
Microarray analysis of gene expression in lupus
@nl
type
label
Microarray analysis of gene expression in lupus
@ast
Microarray analysis of gene expression in lupus
@en
Microarray analysis of gene expression in lupus
@nl
prefLabel
Microarray analysis of gene expression in lupus
@ast
Microarray analysis of gene expression in lupus
@en
Microarray analysis of gene expression in lupus
@nl
P2860
P921
P356
P1476
Microarray analysis of gene expression in lupus
@en
P2093
Jay Wohlgemuth
Mary K Crow
P2860
P2888
P304
P356
10.1186/AR1015
P407
P577
2003-10-13T00:00:00Z
P5875
P6179
1015937099